Today at approximately 15.20, CEO Andreas Bhagwani will present Nanologica at Erik Penser Bank Company Day. The presentation can be followed live here. For more information and schedule of presenting companies, please visit Erik Penser Bank.
Latest News & PR
Nov 23-26, Nanologica will take part of the Biotechgate Digital Partnering event. This is a virtual business development event during four days with the aim of partnering and establishing new global connections. The Biotechgate Digital Partnering is designed to support the business development of Biotech, Medtech and Pharma companies through pre-booked one-on-one meetings.
Starten av Nanologicas kliniska studie med läkemedelskandidaten NIC-001 har flyttats fram ytterligare med anledning av COVID-19. Studien beräknas kunna starta tidigast efter sommaren 2021. Den kliniska studie som avsågs starta under årets tredje kvartal har flyttats fram ytterligare med anledning av COVID-19. Den fortsatta situationen med COVID-19 gör att det under rådande omständigheter är svårt
Nov 18-19 marks the kick off and take off dates for the newly formed Sweden Inhalation Networks. The network is constituted of a small group of scientists with a particular interest in inhaled medicines, that have explored the opportunity to form a Swedish cross disciplinary network. The aim for the network is to maintain and
Nanologica is a public company listed for trade on Spotlight Stock Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.
Presentation of Nanologica
Company presentation made by CEO Andreas Bhagwani on May 28, 2019.
For more videos about the Company as well as video presentations of interim reports, please refer to Investor Relations.